TABLE 7.
Parameters related to falls and fall risk assessed at baseline and at 10 weeks.
| All (n = 45) | Baseline | 10 Weeks | p-level |
| Number of Subjects FGA > 22 | 0 of 45 | 13 of 45 | n/a |
| #Falls (pre-6 mo & in study) | 62 | 17 | n/a |
| Fall Rate (pre-6mo & in study) | 7.7 | 5.4 | 0.27* |
| #Fallers (pre-6mo & in study) | 25 | 22 | n/a |
| # Fall Risk Factors | 4.2 (1.5) | 3.8 (1.6) | 0.047 |
| Pre-Fallers (n = 25) | |||
| Number of Subjects FGA > 22 | 0 of 25 | 4 of 25 | n/a |
| #Falls (pre-6 mo & in study) | 62 | 13 | n/a |
| Fall Rate (pre-6mo & in study) | 13.8 | 7.4 | 0.014* |
| #Fallers (pre-6mo & in study) | 25 | 9 | n/a |
| # Fall Risk Factors | 5.1 (1.3) | 4.3 (1.7) | 0.023 |
| Pre-NonFallers (n = 20) | |||
| Number of Subjects FGA > 22 | 0 of 20 | 9 of 20 | n/a |
| #Falls (pre-6 mo & in study) | 0 | 4 | n/a |
| Fall Rate (pre-6mo & in study) | 0 | 2.9 | 0.125* |
| #Fallers (pre-6mo & in study) | 0 | 4 | n/a |
| # Fall Risk Factors | 3.2 (1.8) | 3.1 (1.7) | 0.76 |
Fall rates are reported in number of falls per 1000 patient days. Fall risk factors are identified in Table 2. In bold if p < 0.05. *Wilcoxon Signed Rank test.